市场调查报告书
商品编码
1410764
腕关节置换市场:按细分市场划分的规模、份额、法规、报销、程序、到 2033 年的预测Wrist Replacement Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
全球约 75% 的人口易患骨关节炎 (OA) 和类风湿性关节炎 (RA),其中只有少数人患有腕部 OA、RA 或腕部骨折或创伤后关节炎等其他适应症。占总数的3-8%。这些疾病的日益普及导致全球对人工手腕植入物的需求不断增加。
由于人口、疾病定义和危险因子的差异,盛行率因地理而异,但在全球范围内,女性受影响最严重。人工腕植入物最初主要是为类风湿性关节炎患者开发的,现在已扩大用于骨关节炎和创伤后关节炎患者。
本报告深入探讨了全球腕关节置换术市场,包括竞争格局、SWOT 分析、到 2033 年的市场预测、COVID-19 的影响以及区域和国家趋势。
Wrist Replacement Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Orthopedic Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Wrist Replacement Devices market for the year 2020 and beyond. About 75% of the global population is prone to Osteoarthritis (OA) and Rheumatoid Arthritis (RA) and only 3-8 per cent of it suffers from wrist OA, RA or other indications like wrist fractures and post traumatic arthritis. Increase in the prevalence of these conditions contributes to an increased demand of wrist replacement implants worldwide.
Although the prevalence rates vary geographically due to variation in population, disease definitions and risk factors but female population are the most affected across the globe. Originally developed primarily for RA patients, wrist replacement implants are now shifting toward greater use in OA and post-traumatic arthritis patients.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Wrist Replacement Devices and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Stryker Corp, Smith & Nephew Plc, KLS Martin LP, and Anika Therapeutics Inc, Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable
Not Applicable
Not Applicable